Medindia
Medindia LOGIN REGISTER
Advertisement

Sysmex America and Medica Corporation Announce Distribution Partnership

Thursday, July 22, 2010 General News
Advertisement
Smaller clinical hematology laboratories to benefit from automated cell image analysis

MUNDELEIN, Ill., July 22 /PRNewswire/ -- Sysmex America, Inc., a leading developer and manufacturer of medical diagnostic instrumentation and information systems, today announced a partnership agreement with Medica Corporation for the exclusive distribution of the EasyCell® assistant to laboratories in North America, Mexico, Argentina, Brazil, Chile and Columbia. Sysmex America will be responsible for instrument sales, marketing and service support.  The EasyCell® assistant is an automated cell image analysis instrument used by hematologists and clinical laboratory technologists to perform white blood cell differentials, platelet estimates and red blood cell morphology.  
Advertisement

"The addition of our robust and highly reliable cell image analysis system to Sysmex America's hematology product offering permits even smaller clinical laboratories to gain the operational efficiencies associated with automating cell differential analysis of stained slides.  We are pleased to serve as Sysmex America's strategic partner in this endeavor," said Robert W. Hagopian, President, Medica Corporation.                      
Advertisement

The EasyCell® assistant enables smaller clinical laboratories to achieve greater detection and examination of abnormal cells while providing more detailed image records compared to other, more traditional manual methods.  This automated system saves the clinical laboratory time and money.  Its unique software also improves data management in the areas of normal differentials, red blood cell morphology, and low-count samples.

"The EasyCell® assistant provides a strong strategic fit that broadens our current portfolio of cell image analysis systems, permitting us to offer highly capable solutions for laboratories of all sizes.  The quality and productivity improvements that correlate with automated cell image analysis can now be realized by smaller clinical laboratories, which is especially important at this pivotal time in our nation's healthcare environment," said John Kershaw, President & CEO, Sysmex America, Inc.  "The addition of the Medica EasyCell® assistant to our current cell image analysis product portfolio provides Sysmex America Inc. with the most comprehensive line of cell image analysis products available to meet our customers' needs."  Sysmex America, Inc. will continue to distribute CellaVision™ cell imaging analysis products.

About Medica Corporation

Based in Bedford, Massachusetts, Medica Corporation uses its proprietary technology to manufacture easy-to-use, low-cost blood testing analyzers.  The analyzers are uniquely easy to operate and service and therefore can be used routinely by most personnel in hospital laboratories.  Medica's products are specifically designed for the small- to medium-sized in-vitro diagnostic clinical laboratory market.  Medica distributes products in North America, Europe, Asia, Africa and the Middle East. Additional information about Medica Corporation can be found at www.medicacorp.com.

About Sysmex America, Inc.

Based in Mundelein, Illinois, Sysmex America, Inc., the U.S. headquarters of Sysmex Corporation (located in Kobe, Japan), is a world leader in clinical laboratory systematization and solutions, including clinical diagnostics, automation and information systems that elevate clinical laboratory medicine to first-line patient care. Sysmex focuses on extending the boundaries of diagnostic science while providing the management information tools that make a real difference in clinical and operational results for people worldwide. Additional information about Sysmex America, Inc. can be found at www.sysmex.com/usa.  

SOURCE Sysmex America, Inc.

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close